Real-time enrollment status for this clostridioides difficile associated disease clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 3:03 AM UTC
| NCT Number | NCT07282665 |
| Recruiting Status | Recruiting |
| Condition | Clostridioides Difficile Associated Disease |
| Phase | PHASE3 |
| Target Enrollment | 32,500 participants |
| Active Locations | 141 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | September 9, 2026 (Sep 9, 2026) |
As of October 13, 2026: Clinical trial NCT07282665 is currently recruiting participants. This phase3 study for clostridioides difficile associated disease is actively seeking new participants at 141 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07282665 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 141 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07282665 was last updated Sep 9, 2026 (September 9, 2026). HelloStudys verifies this status automatically.